your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Care considerations for glucocorticoid (steroid) initiation and use for patients with Duchenne muscular dystrophy
Care considerations for glucocorticoid (steroid) initiation and use for patients with Duchenne muscular dystrophy
CRH: corticotropin-releasing hormone; ACTH: adrenocorticotropic hormone; HPA: hypothalamic-pituitary-adrenal; IM: intramuscular; IV: intravenous. * The PJ Nicholoff tapering protocol is available online.
Original figure modified for this publication. From: Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018; 17:251. Illustration used with the permission of Elsevier Inc. All rights reserved.
